Omnicell Inc (OMCL)
27.86
+0.73
(+2.69%)
USD |
NASDAQ |
Apr 26, 16:00
27.93
+0.07
(+0.25%)
After-Hours: 20:00
Omnicell Net Income (Quarterly): -14.38M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -14.38M |
| September 30, 2023 | 5.553M |
| June 30, 2023 | 3.451M |
| March 31, 2023 | -15.00M |
| December 31, 2022 | -28.41M |
| September 30, 2022 | 16.77M |
| June 30, 2022 | 9.069M |
| March 31, 2022 | 8.213M |
| December 31, 2021 | 13.98M |
| September 30, 2021 | 29.32M |
| June 30, 2021 | 20.42M |
| March 31, 2021 | 14.13M |
| December 31, 2020 | 16.38M |
| September 30, 2020 | 8.805M |
| June 30, 2020 | -4.299M |
| March 31, 2020 | 11.31M |
| December 31, 2019 | 22.10M |
| September 30, 2019 | 19.98M |
| June 30, 2019 | 15.98M |
| March 31, 2019 | 3.284M |
| December 31, 2018 | 14.79M |
| September 30, 2018 | 13.63M |
| June 30, 2018 | 6.588M |
| March 31, 2018 | 2.72M |
| December 31, 2017 | 31.22M |
| Date | Value |
|---|---|
| September 30, 2017 | 7.748M |
| June 30, 2017 | 1.88M |
| March 31, 2017 | -10.34M |
| December 31, 2016 | 9.31M |
| September 30, 2016 | 1.983M |
| June 30, 2016 | -1.159M |
| March 31, 2016 | -0.378M |
| December 31, 2015 | 7.655M |
| September 30, 2015 | 8.036M |
| June 30, 2015 | 8.751M |
| March 31, 2015 | 6.318M |
| December 31, 2014 | 9.236M |
| September 30, 2014 | 7.30M |
| June 30, 2014 | 7.789M |
| March 31, 2014 | 6.194M |
| December 31, 2013 | 6.823M |
| September 30, 2013 | 7.755M |
| June 30, 2013 | 6.016M |
| March 31, 2013 | 3.385M |
| December 31, 2012 | 5.532M |
| September 30, 2012 | 6.92M |
| June 30, 2012 | 1.375M |
| March 31, 2012 | 2.351M |
| December 31, 2011 | 4.138M |
| September 30, 2011 | 2.994M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-28.41M
Minimum
Dec 2022
29.32M
Maximum
Sep 2021
8.072M
Average
11.31M
Median
Mar 2020
Net Income (Quarterly) Benchmarks
| Teladoc Health Inc | -28.89M |
| American Shared Hospital Services | 0.415M |
| Novo Integrated Sciences Inc | -2.746M |
| Astrana Health Inc | 12.36M |
| Cryo-Cell International Inc | 0.5562M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 258.85M |
| Total Expenses (Quarterly) | 282.21M |
| EPS Diluted (Quarterly) | -0.32 |
| Enterprise Value | 1.369B |
| Gross Profit Margin (Quarterly) | 40.72% |
| Profit Margin (Quarterly) | -5.55% |
| Earnings Yield | -1.62% |
| Normalized Earnings Yield | -1.615 |